The Samuel Waxman Cancer Research Foundation to honor Craig B. Thompson, M.D., President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center, with David T. Workman Award at the SWCRF Breakthroughs Scientific Symposium 


Craig B. Thompson, M.D.

 

 

New York, NY, March 7, 2018 – The Samuel Waxman Cancer Research Foundation (SWCRF) today announced it will present the 2018 David T. Workman Memorial Award to Craig B. Thompson, M.D., President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center (MSK), at its SWCRF Breakthroughs Scientific Symposium on April 30 at the Leon and Norma Hess Center for Science and Medicine at Mount Sinai Medical Center. The event brings together SWCRF grantees, scientific leaders and stakeholders to mark the annual evaluation of SWCRF funded research programs. 

The David T. Workman Memorial Award honors the memory of David T. Workman, one of the most influential leaders of the SWCRF, and is a biennial recognition and two-year grant bestowed on scientists who develop novel therapies for poorly treatable cancer types.  Dr. Thompson is being honored for his leadership role in the development of the AG-221 therapy for acute myeloid leukemia (AML) that blocked the IDH1-2 enzyme’s disruption of normal cell maturation. 

“We are excited to celebrate the achievements of Dr. Craig Thompson,” said Dr. Samuel Waxman, M.D., Founder and CEO of the SWCRF. “He played a major role in bringing cancer metabolism into the mainstream by identifying the importance of IDH1-2 mutations in cancer cell differentiation to create a novel therapy. This breakthrough work perfectly embodies the spirit of the David Workman Award.” 

Past recipients of the David T. Workman Memorial Award include Drs. Waun Ki Hong and Reuben Lotan of MD Anderson Cancer Center, Michael Grever, Chair, Department of Internal Medicine, Ohio State University, Douglas Lowy and John Schiller of The National Institutes of Health, Stephen Baylin of Johns Hopkins University School of Medicine, Peter Jones, University of Southern California Norris Comprehensive Cancer Center, Alan Ashworth of The Institute of Cancer Research,  Kenneth Anderson, Dana Farber Cancer Institute, and Timothy J. Ley, Washington University. 

SWCRF Breakthroughs, which will feature presentations by SWCRF founder and CEO Samuel Waxman, M.D., and SWCRF Chief Scientific Officer Jonathan Licht, M.D., and a keynote address by Dr. Thompson, closes the Foundation’s two-day scientific review that brings together its international network of collaborating scientists to present project updates evaluated by the SAB as part of the Foundation’s grants review process. Grantees hail from leading cancer research institutions, including Dana-Farber Cancer Institute, Johns Hopkins University, Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, Sheba Medical Center, the Shanghai Institute of Hematology and Weill Cornell Medical Center, among many others.

The SWCRF SAB includes Lorraine Gudas, Ph.D., Weill Cornell Medical Center; Robert Hromas, M.D., FACP, University of Texas Health; Ramon Parsons, M.D., Ph.D., Icahn School of Medicine at Mount Sinai Medical Center; Nancy Speck, Ph.D., University of Pennsylvania; Martin S. Tallman, M.D., Memorial Sloan Kettering Cancer Center, and Hua Yu, Ph.D., City of Hope. 

About Craig B. Thompson, M.D.

Craig B. Thompson, M.D., is the President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center (MSK). Dr. Thompson received his BS from Dartmouth and MD from the University of Pennsylvania, followed by clinical training in internal medicine at Harvard Medical School and in medical oncology at the Fred Hutchinson Cancer Research Institute. Dr. Thompson has extensive research experience in cancer, immunology, and translational medicine. His current research focuses on the regulation of cellular metabolism during cell growth/differentiation and on the role that metabolic changes play in the origin and progression of cancer. Dr. Thompson is a member of the Institute of Medicine, the National Academy of Sciences, the American Academy of Arts and Sciences, and the Medical Advisory Board of the Howard Hughes Medical Institute. He is also a Fellow of the AACR Academy. 

 

For more information about the SWCRF Breakthroughs Scientific Symposium, or to RSVP, contact Edgar Trinidad at etrinidad@waxmancancer.org or 646-398-5261.